Phase IIa trial of ISC-hpNSC in patients with Parkinson's disease

Trial Profile

Phase IIa trial of ISC-hpNSC in patients with Parkinson's disease

Planning
Phase of Trial: Phase II

Latest Information Update: 16 Mar 2016

At a glance

  • Drugs ISC-hpNSC (Primary)
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Sponsors International Stem Cell Corporation
  • Most Recent Events

    • 16 Mar 2016 New trial record
    • 14 Apr 2015 According to a media release, International Stem Cell Corporation has submitted a CTX application to the Australian regulatory authorities and plans to initiate the trial within the next few months.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top